Who is sponsoring CATCH-AF?

CATCH-AF is sponsored by The Cleveland Clinic.

What condition does CATCH-AF study?

CATCH-AF studies Congestive Heart Failure, Left Ventricular Failure, Atrial Fibrillation.

What drugs are being tested in CATCH-AF?

Interventions: Catheter Ablation, FDA approved anti arrhythmic drug.

What is the status of CATCH-AF?

CATCH-AF is currently TERMINATED.

Last reviewed 2025-05-19 · How we verify

Catheter Ablation vs. Medical Therapy in Congested Hearts With AF (CATCH-AF in Patients With Impaired LV Function): An Early Ablation Strategy Study Impact on Health Care Utilization

NCT02686749 Phase 4 TERMINATED Results posted

This study is a multi-center, randomized, unblinded, clinical trial. The objective is to determine if catheter-based atrial fibrillation (AF) ablation is superior to medical treatment in patients with impaired left ventricular (LV) function who have been diagnosed with symptomatic AF within the past 12 months.

Details

Lead sponsor	The Cleveland Clinic
Phase	Phase 4
Status	TERMINATED
Enrolment	4
Start date	2016-06
Completion	2018-10-01

Conditions

Congestive Heart Failure
Left Ventricular Failure
Atrial Fibrillation

Interventions

Catheter Ablation
FDA approved anti arrhythmic drug

Primary outcomes

First Hospitalization for Heart Failure, Recurrence of AF or Direct Current Cardioversion — 12 months
Time measured in days to first hospitalization for heart failure, recurrence of AF or Direct Current cardioversion after the treatment period (first 3 months post enrollment or post procedure during which repeat ablation can be performed and titration of AADs can be performed).

Countries

United States